摘要:
The invention relates to the use of plasminogen non-neurotoxic activators factors, for example from Desmodus rotundus (DSPA) or genetically modified plasminogen activator factors of human origin for producing an injection therapeutic agent for therapeutically treating human cerebral stroke.
摘要:
The invention concerns the use and the production of non-neurotoxic plasminogen activating factors, derived for example from the common vampire Desmodus rotundus (DSPA), for therapeutic treatment of stroke in humans. The invention provides a novel therapeutic base for treating stroke in humans.